These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 7697695)
1. Effect of intravenous administration of EM523L on gastric emptying and plasma glucose levels after a meal in patients with diabetic gastroparesis: a pilot study. Nakamura T; Ishii M; Arai Y; Tandoh Y; Terada A; Takebe K Clin Ther; 1994; 16(6):989-99. PubMed ID: 7697695 [TBL] [Abstract][Full Text] [Related]
2. Erythromycin derivative improves gastric emptying and insulin requirement in diabetic patients with gastroparesis. Ishii M; Nakamura T; Kasai F; Baba T; Takebe K Diabetes Care; 1997 Jul; 20(7):1134-7. PubMed ID: 9203450 [TBL] [Abstract][Full Text] [Related]
3. Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes. Ozaki K; Monnai M; Onoma M; Muramatsu H; Yogo K; Watanabe T; Oda Y; Katagiri K; Arakawa H; Itoh Z; Omura S; Takanashi H J Diabetes Complications; 2008; 22(5):339-47. PubMed ID: 18413164 [TBL] [Abstract][Full Text] [Related]
4. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. Janssens J; Peeters TL; Vantrappen G; Tack J; Urbain JL; De Roo M; Muls E; Bouillon R N Engl J Med; 1990 Apr; 322(15):1028-31. PubMed ID: 2320062 [TBL] [Abstract][Full Text] [Related]
5. Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis. Russo A; Stevens JE; Giles N; Krause G; O'Donovan DG; Horowitz M; Jones KL Aliment Pharmacol Ther; 2004 Aug; 20(3):333-8. PubMed ID: 15274670 [TBL] [Abstract][Full Text] [Related]
6. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Richards RD; Davenport K; McCallum RW Am J Gastroenterol; 1993 Feb; 88(2):203-7. PubMed ID: 8424421 [TBL] [Abstract][Full Text] [Related]
7. Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug. Lehmann R; Honegger RA; Feinle C; Fried M; Spinas GA; Schwizer W Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):255-61. PubMed ID: 12951630 [TBL] [Abstract][Full Text] [Related]
8. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study. McCallum RW; Cynshi O; Aliment Pharmacol Ther; 2007 Oct; 26(8):1121-30. PubMed ID: 17894654 [TBL] [Abstract][Full Text] [Related]
9. Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis. Onoma M; Ozaki K; Yogo K; Monnai M; Muramatsu H; Kamei K; Kawabe Y; Hayashi S; Shiga T; Matsuo S; Suzuki M; Itoh Z; Omura S; Takanashi H Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):788-96. PubMed ID: 18346169 [TBL] [Abstract][Full Text] [Related]
10. Gastric emptying of solid and liquid meals in healthy controls compared with long-term type-1 diabetes mellitus under optimal glucose control. Folwaczny C; Wawarta R; Otto B; Friedrich S; Landgraf R; Riepl RL Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):223-9. PubMed ID: 12845561 [TBL] [Abstract][Full Text] [Related]
11. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Tack J; Depoortere I; Bisschops R; Verbeke K; Janssens J; Peeters T Aliment Pharmacol Ther; 2005 Nov; 22(9):847-53. PubMed ID: 16225494 [TBL] [Abstract][Full Text] [Related]
13. Gastric emptying of liquids and solids evaluated by acetaminophen test in diabetic patients with and without autonomic neuropathy. Cavallo-Perin P; Aimo G; Mazzillo A; Riccardini F; Pagano G Riv Eur Sci Med Farmacol; 1991; 13(5-6):205-9. PubMed ID: 1819847 [TBL] [Abstract][Full Text] [Related]
14. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs. Onoma M; Yogo K; Ozaki K; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625 [TBL] [Abstract][Full Text] [Related]
15. Effects of EM574 and cisapride on gastric contractile and emptying activity in normal and drug-induced gastroparesis in dogs. Tanaka T; Mizumoto A; Mochiki E; Suzuki H; Itoh Z; Omura S J Pharmacol Exp Ther; 1998 Nov; 287(2):712-9. PubMed ID: 9808701 [TBL] [Abstract][Full Text] [Related]
16. [Acetaminophen absorption test for determination of diabetic gastroparesis and effects of erythromycin on gastric emptying]. Feng B; Li Y; Li C Zhonghua Nei Ke Za Zhi; 1996 Mar; 35(3):178-81. PubMed ID: 9387657 [TBL] [Abstract][Full Text] [Related]
17. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients. Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675 [TBL] [Abstract][Full Text] [Related]
18. EM523L, a nonpeptide motilin agonist, stimulates gastric emptying and pancreatic polypeptide secretion. Okano H; Inui A; Ueno N; Morimoto S; Ohmoto A; Miyamoto M; Aoyama N; Nakajima Y; Baba S; Kasuga M Peptides; 1996; 17(6):895-900. PubMed ID: 8899806 [TBL] [Abstract][Full Text] [Related]
19. Effect of oral erythromycin on patients with diabetic gastroparesis. Pan DY; Chen GH; Chang CS; Ho KS; Poon SK; Huang CK; Kao CH; Wang SJ Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):447-51. PubMed ID: 7634182 [TBL] [Abstract][Full Text] [Related]
20. Effect of motilin on the gastric emptying of glucose and fat in humans. Christofides ND; Long RG; Fitzpatrick ML; McGregor GP; Bloom SR Gastroenterology; 1981 Mar; 80(3):456-60. PubMed ID: 7004999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]